Prostate Cancer: Screening, Biopsy, and Management

Credits: 1.25

Best suited for: Urologists

Course Description

When it comes to screening and diagnosis of prostate cancer, we’re still in the “Good, the Bad, and the Ugly” of the wild west. The good is that 50% fewer men are dying of prostate cancer. The bad is that we face a pandemic of over-diagnosis and over-treatment. And the ugly? Unfounded screening and treatment patterns promoted within urology, primary care, and even the U.S. Preventive Services Task Force.
In this 1.25-hour webinar, Dr. Scott Eggener walks you through the landscape of PSA, pointing out the components of smart screening that will minimize over-detection. He demonstrates best practice related to novel bio markers through case examples, including what you need to discuss with your newly-diagnosed patients. Finally, he reviews medico-legal considerations and strategies for active surveillance that encompass transition to inactive surveillance. The webinar concludes with a short Q & A that highlights important issues, featuring Dr. Ernest Sussman, Vice President of Risk Management at SCRUBS Risk Retention Group.

Learning Objectives
Urologists who complete this course will be able to:
  • List the five components of “smart” screening
  • Describe best practice related to novel screening biomarkers
  • Cite five key recommendations related to biopsy
  • Discuss five important recommendations for discussion with patients newly diagnosed with prostate cancer


Faculty Information

Scott Eggener, MD, is an experienced robotic and open surgeon who co-directs the Prostate Cancer Program at the University of Chicago Medicine. His research—which has resulted in over 200 publications—exclusively focuses on urologic cancers and primarily focuses on improving the screening and care of men with prostate cancer. Dr. Eggener’s research has been presented at national and international meetings. He is a senior faculty scholar at the Bucksbaum Institute for Clinical Excellence, an associate editor at four medical journals, on the Executive Board of IVUMed, and frequently participates in volunteer educational and surgical international missions.y.

Planning Group

Ernest Sussman, MD – VP, SCRUBS Risk Retention Group, Stuart, FL, Urology, Las Vegas, NV
Mary Ancheta – Risk Management Education Assistant, Physicians Insurance, Seattle, WA
Anne Flitcroft, RN, BSN, CPHRM – Senior Healthcare Risk Management Consultant, Physicians Insurance, Seattle, WA
Mesina McMurray – Content Development Project Manager, Physicians Insurance, Seattle, WA
Celia Smith, CHCP – Director, Continuing Medical Education, Physicians Insurance, Seattle, WA

Original release: February 2017

Last reviewed: February 2018

Expiration: February 2020

CME Information

Category 1 credit is applicable throughout the United States.

 Estimated time to complete this activity:  1.25 hours

Physicians in Washington who complete this course will fulfill the risk management education requirement mandated by the Washington Health Services Act of 1993.

Physicians Insurance/Experix is accredited by the Washington State Medical Association to provide continuing medical education for physicians.
Physicians Insurance/Experix designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity meets the criteria for up to 1.25 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.

Dr. Eggener has had speaking and/or consultant roles for MDx Health, OPKO, and Genomic Health within the past year.
All planning and peer-review group members certified that neither they nor their spouses/partners have, nor have had within the past year, any financial arrangements or affiliation with any commercial organization involved in the health care goods or services consumed by or used on patients, with the exemption of non-profit or government organizations and non-health care related companies.
The content does not include mention of unapproved or investigational uses or products or devices.

Resolution of Conflicts of Interest
Physicians Insurance/Experix has implemented a process to resolve conflicts of interest for each continuing medical education activity, to help ensure content objectivity, independence, fair balance, and content that is aligned with the interest of the public. Conflicts, if any, are resolved through a peer-review process.

* If you are a member of Physicians Insurance, all CME courses are included with your premium. Click here to access members-only CME.